Immunitybio Correlations

IBRX Stock  USD 2.24  0.04  1.82%   
The current 90-days correlation between Immunitybio and Arcus Biosciences is 0.14 (i.e., Average diversification). The correlation of Immunitybio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Immunitybio Correlation With Market

Modest diversification

The correlation between Immunitybio and DJI is 0.27 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Immunitybio and DJI in the same portfolio, assuming nothing else is changed.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunitybio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Immunitybio Stock please use our How to Invest in Immunitybio guide.

Moving together with Immunitybio Stock

  0.7KG Kestrel Group Symbol ChangePairCorr
  0.75HPQ HP IncPairCorr

Moving against Immunitybio Stock

  0.75CUB Lionheart HoldingsPairCorr
  0.75TRV The Travelers CompaniesPairCorr
  0.67DD Dupont De NemoursPairCorr
  0.6XOM Exxon Mobil CorpPairCorr
  0.56LION Lionsgate Studios HoldingPairCorr
  0.45JNJ Johnson JohnsonPairCorr
  0.44PFE Pfizer IncPairCorr
  0.39BAC Bank of America Earnings Call This WeekPairCorr
  0.38CAT CaterpillarPairCorr
  0.37VZ Verizon CommunicationsPairCorr
  0.34AA Alcoa CorpPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

LQDACOGT
LQDARCUS
COGTRCUS
VRDNCOGT
VRDNLQDA
VRDNRCUS
  

High negative correlations

AGIOLQDA
VRDNRXRX
AGIOCOGT
AGIORCUS
RXRXCOGT
LQDARXRX

Risk-Adjusted Indicators

There is a big difference between Immunitybio Stock performing well and Immunitybio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Immunitybio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
RCUS  2.97  0.59  0.15  0.50  3.71 
 6.96 
 28.33 
DNLI  2.67  0.13  0.05  0.17  3.15 
 6.50 
 23.32 
ETNB  0.08  0.01  0.00  0.77  0.00 
 0.27 
 0.34 
COGT  4.94  1.68  0.61  0.53  2.28 
 5.94 
 123.47 
GLPG  1.22 (0.07) 0.00 (0.19) 0.00 
 2.21 
 10.22 
BEAM  3.24  0.04  0.03  0.09  3.28 
 7.82 
 25.25 
RXRX  4.30 (0.32) 0.00 (0.04) 0.00 
 11.43 
 26.43 
LQDA  3.01  0.52  0.13  0.89  3.43 
 8.00 
 19.63 
AGIO  3.25 (0.30) 0.00 (0.16) 0.00 
 5.99 
 56.88 
VRDN  2.08  0.55  0.23  0.91  1.95 
 5.57 
 16.00 

Immunitybio Corporate Management

Jason JDGeneral SecretaryProfile
Sandeep MDChief OfficerProfile
Helen LuuChief OfficerProfile
Leonard MDChief OfficerProfile
Jason LiljestromGeneral SecretaryProfile
Bruce MDSenior AffairsProfile